Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes

Archives of Ophthalmology

Volumn 118, Issue 5, 2000, Pages 659-663

  Hrach, Charles J ^a   Johnson, Mark W ^a,b   Hassan, Adam S ^a   Lei, Bo ^a   Sieving, Paul A ^a   Elner, Victor M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; EYE TOXICITY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0034034610     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.5.659     Document Type: Article

References (18)

1. Jaffe GJ, Abrams GW, Williams GA, Han DP. Tissue plasminogen activator for postvitrectomy fibrin formation. Ophthalmology. 1990;97:184-189.
2. Williams DF, Bennett SR, Abrams GW, et al. Low-dose intraocular tissue plasminogen activator for treatment of postvitrectomy fibrin formation [letter]. Am J Ophthalmol. 1990;109:606-607.
3. sis during surgical evacuation of experimental subretinal hemorrhage. Ophthalmology. 1992;99:515-521.
4. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol. 1994;118:559-568.
5. Kamei M, Tano Y, Maeno T, et al. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol. 1996;121:267-275.
6. Kimura AE, Reddy CV, Folk JC, et al. Removal of subretinal hemorrhage facilitated by preoperative intravitreal tissue plasminogen activator [letter]. Retina. 1994;14:83-84.
7. Heriot WJ. Further experience in management of submacular hemorrhage with intravitreal tPA. Paper presented at: American Academy of Ophthalmology Vitreoretinal Update; October 24, 1997; San Francisco, Calif.
8. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreal tPA injection and pneumatic displacement. Ophthalmology. 1999;106:1900-1906.
9. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers. 1999;30:427-434.
10. Johnson MW, Olsen KR, Hernandez E, et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol. 1990;108:259-263.
11. Loewenstein A, Zemel E, Lazar M, et al. Drug-induced retinal toxicity in albino rabbits: the effects of imipenem and aztreonam. Invest Ophthalmol Vis Sci. 1993; 34:3468-3476.
12. Polyak S. The cat. In: The Vertebrate Visual System. Chicago. Ill: University of Chicago Press; 1957:99-127.
13. Egana BC, LaPuente CR, Peyman GA. Intravitreal distribution of tissue plasminogen activator in nonvitrectomized and fibrin-filled vitrectomized eyes [abstract]. Invest Ophthalmol Vis Sci. 1997;38(suppl):212.
14. Irvine WD, Johnson MW, Hernandez E. et al. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol. 1991;109:718-722.
15. Gilbert H. Pigmentary retinopathy following intravitreal injection of tissue plasminogen activator. Paper presented at: Vitreous Society Annual Meeting: September 20, 1997; New Orleans, La.
16. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol. 1999;237:273-277.
17. LaPuente CR, Peyman GA, Egana BC, et al. Guidelines for intravitreal treatment of vascular occlusions with rtPA [abstract]. Invest Ophthalmol Vis Sci. 1998;39(suppl):988.
18. Zemel E, Loewenstein A, Lei B, et al. Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity. Invest Ophthalmol Vis Sci. 1995;36:1875-1884.